Merz appoints new president, CEO

GREENSBORO, N.C. Merz Pharmaceuticals, whose brands include Mederma Skin Care for Scars, Appearex for nails and Aqua Glycolic skin care system, has appointed Jack Britts president and chief executive officer.

In his new role, Britts will oversee further growth of Merz’ current medical dermatology business and establish two new business units to support the company?s product pipeline in aesthetics and neurology.

Prior to joining Merz, Britts spent eight years at Sepracor, a research-based pharmaceutical company focused on the treatment of respiratory and central nervous system disorders. At Sepracor he was group vice president in charge of commercial operations, where, among other product development activities, he was responsible for the commercialization of Lunesta.

From 1986 to 2000, he held various executive positions at AstraZeneca, where he last served as vice president of Therapeutic Area Leader Gastrointestinal Products. His experience also includes an international assignment as general manager for Zeneca business in Central and Eastern Europe, Turkey and the Middle East and Africa.